TScan Therapeutics Inc (TCRX)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Assets | 152.42M | 165.45M | 199.09M | 173.58M | 316.92M | 291.38M | 272.15M | 240.83M |
Total Current Assets | 129.36M | 141.18M | 124.13M | 100.91M | 242.22M | 217.57M | 194.24M | 164.72M |
Cash and Equivalents | 125.6M | 137.31M | 120.03M | 95.61M | 208.84M | 155.19M | 133.36M | 140.51M |
Total Non-Current Assets | 23.06M | 24.28M | 85.06M | 72.67M | 74.71M | 73.81M | 85.65M | 76.11M |
Total Liabilities | 20.76M | 48.8M | 99.66M | 95.56M | 126.32M | 122.42M | 121.28M | 117.87M |
Total Current Liabilities | 17.17M | 16.59M | 17.31M | 14.05M | 35.12M | 33.15M | 29.82M | 31.48M |
Total Non-Current Liabilities | 3.59M | 61.28M | 111.64M | 111.02M | 120.92M | 118.1M | 118.16M | 109.84M |
Common Equity | 3k | 3k | 3k | 3k | 5k | 5k | 5k | 5k |
Retained Earnings | -123.41M | -139.66M | -158.38M | -180.94M | -204.99M | -227.98M | -247.6M | -277.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 49.38M | 49.74M | 188.11M | 199.09M | 272.15M |
Total Current Assets | 42.38M | 36.45M | 165.65M | 124.13M | 194.24M |
Cash and Equivalents | 41.76M | 34.79M | 161.41M | 120.03M | 133.36M |
Total Non-Current Assets | -17.14M | -42.46M | 160.78M | 99.43M | 150.87M |
Total Liabilities | 6.84M | 32.52M | 27.33M | 99.66M | 121.28M |
Total Current Liabilities | 2.4M | 17.45M | 21.34M | 17.31M | 29.82M |
Total Non-Current Liabilities | 4.44M | 15.07M | 5.99M | 111.64M | 118.16M |
Total Equity | -17.14M | -42.46M | 160.78M | 99.43M | 150.87M |
Common Equity | 0 | 1,000 | 3k | 3k | 5k |
Retained Earnings | -17.41M | -43.53M | -92.16M | -158.38M | -247.6M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.